Current Neuro-Oncology




Volume 23 Number 23
15 November 2021




Home > Publications > Current Neuro-Oncology > Volume 23, Year 2021 > Number 23, 15 November






Fries C, Girvin AR, Korones DN, Weintraub L, Fitzpatrick L, Andolina JR.
Myeloablative Carboplatin and Thiotepa With Autologous Stem Cell Rescue for Nonmedulloblastoma High-risk CNS Tumors in Young Children.
J Pediatr Hematol Oncol. 2021 Nov 1, 2021;43(8):e1223-e1227
. doi: 10.1097/MPH.0000000000002198. PMID: 34001790. Observational study˰ ˍ




Rahimy E, Dudley SA, von Eyben R, Pollom EL, Seiger K, Modlin L, Wynne J, Fujimoto D, Jacobs LR, Chang SD, Gibbs IC, Hancock SL, Adler JR, Li G, Choi CYH, Soltys SG.
Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases: Health-related Quality of Life Outcomes.
Am J Clin Oncol. 2021 Nov 1, 2021;44(11):588-595
. doi: 10.1097/COC.0000000000000868. PMID: 34670228. Interventional study˰ ˍ




Huang B, Yu Z, Liang R.
Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival.
BMC Neurol. 2021 Nov 2, 2021;21(1):424
. doi: 10.1186/s12883-021-02461-9. PMID: 34724914. Observational study. ˍ




Lassman AB, Wen PY, van den Bent MJ, Plotkin SR, Walenkamp AME, Green AL, Li K, Walker CJ, Chang H, Tamir S, Henegar L, Shen Y, Alvarez MJ, Califano A, Landesman Y, Kauffman MG, Shacham S, Mau-Sørensen M.
A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma.
Clin Cancer Res. 2021 Nov 2, 2022;28(3):452-460
. doi: 10.1158/1078-0432.CCR-21-2225. PMID: 34728525. Interventional study. ˍ




Jacobo JA, Vazquez-Gregorio R, Moreno-Jimenez S, Mejia-Perez S.
Decompressive craniectomy: A salvage treatment for patients with central nervous system tumors.
Cir Cir. 2021 Nov 3, 2021;89(5):603-610
. doi: 10.24875/CIRU.20000808. PMID: 34665170. Observational study. ˍ




Gregucci F, Surgo A, Bonaparte I, Laera L, Ciliberti MP, Carbonara R, Gentile MA, Giraldi D, Calbi R, Caliandro M, Sasso N, D'Oria S, Somma C, Martinelli G, Surico G, Lombardi G, Fiorentino A.
Poor-Prognosis Patients Affected by Glioblastoma: Retrospective Study of Hypofractionated Radiotherapy with Simultaneous Integrated Boost and Concurrent/Adjuvant Temozolomide.
J Pers Med. 2021 Nov 4, 2021;11(11):1145
. doi: 10.3390/jpm11111145. PMID: 34834497. Observational study. ˍ




Bonneville-Levard A, Frappaz D, Tredan O, Lavergne E, Corset V, Agrapart V, Chabaud S, Pissaloux D, Wang Q, Attignon V, Cartalat S, Ducray F, Thomas-Maisonneuve L, Honnorat J, Meyronet D, Taillandier L, Blonski M, Viari A, Baudet C, Sohier E, Lantuejoul S, Paindavoine S, Treilleux I, Rodriguez C, Pérol D, Blay JY.
Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial.
Med Oncol. 2021 Nov 5, 2021;39(1):4
. doi: 10.1007/s12032-021-01536-4. PMID: 34739635. Interventional study˰ ˍ




Bunevicius A, Pikis S, Kondziolka D, Patel DN, Bernstein K, Sulman EP, Lee CC, Yang HC, Delabar V, Mathieu D, Cifarelli CP, Arsanious DE, Dahshan BA, Weir JS, Speckter H, Mota A, Tripathi M, Kumar N, Warnick RE, Sheehan JP.
Stereotactic radiosurgery for glioblastoma considering tumor genetic profiles: an international multicenter study.
J Neurosurg. 2021 Nov 5, 2021:1-9
. doi: 10.3171/2021.7.JNS211277. PMID: 34740186. Observational study. ˍ




Que T, Zheng H, Tan JE, Yi G, Lin Z, Liu J, Xu H, Zheng X, Zhang XA, Li Z, Huang G.
Ventricle wall resection contributes to supramaximal resection and prognosis in SVZ-involved frontal gliomas: A single center retrospective study.
Clin Neurol Neurosurg. 2021 Nov 6, 2021;211:107015
. doi: 10.1016/j.clineuro.2021.107015. PMID: 34775256. Observational study˰ ˍ



*

Dottermusch M, Uksul N, Knappe UJ, Erdlenbruch B, Wefers AK.
An H3F3A K27M-mutation in a sonic hedgehog medulloblastoma.
Brain Pathol. 2021 Nov 7, 2022 May;32(3):e13024
. doi: 10.1111/bpa.13024. PMID: 34747078. Case report. ˍ




Budnick HC, Richardson AM, Shiue K, Watson G, Ng SK, Le Y, Shah MV.
GammaTile for Gliomas: A Single-Center Case Series.
Cureus. 2021 Nov 9, 2021;13(11):e19390
. doi: 10.7759/cureus.19390. PMID: 34925992. Case report. ˍ




El-Abtah ME, Wenke MR, Talati P, Fu M, Kim D, Weerasekera A, He J, Vaynrub A, Vangel M, Rapalino O, Andronesi O, Arrillaga-Romany I, Forst DA, Yen YF, Rosen B, Batchelor TT, Gonzalez RG, Dietrich J, Gerstner ER, Ratai EM.
Myo-Inositol Levels Measured with MR Spectroscopy Can Help Predict Failure of Antiangiogenic Treatment in Recurrent Glioblastoma.
Radiology. 2021 Nov 9, 2022;302(2):410-418
. doi: 10.1148/radiol.2021210826. PMID: 34751617. Interventional study˰ ˍ




Ellingson BM, Kim GHJ, Brown M, Lee J, Salamon N, Steelman L, Hassan I, Pandya SS, Chun S, Linetsky M, Yoo B, Wen PY, Mellinghoff IK, Goldin J, Cloughesy TF.
Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib.
Neuro Oncol. 2021 Nov 9, 2022;24(5):770-778
. doi: 10.1093/neuonc/noab256. PMID: 34751786. Interventional study. ˍ




Patil N, Somasundaram E, Waite KA, Lathia JD, Machtay M, Gilbert MR, Connor JR, Rubin JB, Berens ME, Buerki RA, Choi S, Sloan AE, Penas-Prado M, Ashby LS, Blumenthal DT, Werner-Wasik M, Hunter GK, Flickinger JC, Wendland MM, Panet-Raymond V, Robins HI, Pugh SL, Mehta MP, Barnholtz-Sloan JS.
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.
J Neurooncol. 2021 Nov 10, 2021;155(3):363-372
. doi: 10.1007/s11060-021-03886-5. PMID: 34761331. Observational study. ˍ




Franchino F, Morra I, Forni M, Bertero L, Zanini C, Roveta F, Ricardi U, Mantovani C, Carpaneto A, Migliore E, Pellerino A, Ferrio F, Cassoni P, Garbossa D, Soffietti R, Ruda' R.
Medulloblastoma in adults: an analysis of clinico-pathological, molecular and treatment factors.
J Neurosurg Sci. 2021 Nov 11
. doi: 10.23736/S0390-5616.21.05548-X. PMID: 34763393. Observational study˰ ˍ



*

Tsuji Y, Nonoguchi N, Okuzaki D, Wada Y, Motooka D, Hirota Y, Toho T, Yoshikawa N, Furuse M, Kawabata S, Miyatake SI, Nakamura H, Yamamoto R, Nakamura S, Kuroiwa T, Wanibuchi M.
Chronic pathophysiological changes in the normal brain parenchyma caused by radiotherapy accelerate glioma progression.
Sci Rep. 2021 Nov 11, 2021;11(1):22110
. doi: 10.1038/s41598-021-01475-0. PMID: 34764346. Laboratory investigation. ˍ




Vaugier L, Ah-Thiane L, Aumont M, Jouglar E, Campone M, Colliard C, Doucet L, Frenel JS, Gourmelon C, Robert M, Martin SA, Riem T, Roualdes V, Campion L, Mervoyer A.
Standard 6-week chemoradiation for elderly patients with newly diagnosed glioblastoma.
Sci Rep. 2021 Nov 11, 2021;11(1):22057
. doi: 10.1038/s41598-021-01537-3. PMID: 34764361. Observational study. ˍ




Baliga S, Gallotto S, Bajaj B, Lewy J, Weyman E, Lawell MP, Yeap BY, Ebb DE, Huang M, Caruso P, Perry A, Jones RM, MacDonald SM, Tarbell NJ, Yock TI.
Decade-long disease, secondary malignancy, and brainstem injury outcomes in pediatric and young adult medulloblastoma patients treated with proton radiotherapy.
Neuro Oncol. 2021 Nov 12, 2022;24(6):1010-1019
. doi: 10.1093/neuonc/noab257. PMID: 34788463. Observational study. ˍ




Easwaran TP, Sterling D, Ferreira C, Sloan L, Wilke C, Neil E, Shah R, Chen CC, Dusenbery KE.
Rapid Interval Recurrence of Glioblastoma Following Gross Total Resection: A Possible Indication for GammaTileⓇ Brachytherapy.
Cureus. 2021 Nov 12, 2021;13(11):e19496
. doi: 10.7759/cureus.19496. PMID: 34912636. Case report. ˍ




Simonelli M, Persico P, Capucetti A, Carenza C, Franzese S, Lorenzi E, Dipasquale A, Losurdo A, Giordano L, Pessina F, Navarria P, Politi LS, Mavilio D, Locati M, Della Bella S, Santoro A, Bonecchi R.
Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytes.
Neurooncol Adv. 2021 Nov 13, 2021;3(1):vdab160
. doi: 10.1093/noajnl/vdab160. PMID: 34901858. Interventional study. ˍ




Mehta S, Vassantachart AK, Fossum CC, Yang W, Shen ZL, Chang KE, Ye JC, Chen TC, Chang EL.
Surviving Over a Decade With Glioblastoma: A Clinical Course Characterized by Multiple Recurrences, Numerous Salvage Treatments, and Novel Use of Cesium-131 Tiles.
Cureus. 2021 Nov 14, 2021;13(11):e19573
. doi: 10.7759/cureus.19573. PMID: 34926045. Case report. ˍ




Butt OH, Zhou AY, Huang J, Leidig WA, Silberstein AE, Chheda MG, Johanns TM, Ansstas G, Liu J, Talcott G, Nakiwala R, Shimony JS, Kim AH, Leuthardt EC, Tran DD, Campian JL.
A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma.
Neurooncol Adv. 2021 Nov 15, 2021;3(1):vdab164
. doi: 10.1093/noajnl/vdab164. PMID: 34988450. Interventional study. ˍ